Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enantioselective Hydrolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102757924A details a novel Rhodococcus strain for high-purity (S)-(+)-DMCPA production, offering superior enantioselectivity and scalable manufacturing for cilastatin synthesis.
Patent CN102382785B reveals a novel Morganella morganii strain for high-purity Pregabalin intermediate production, offering significant cost and supply chain advantages.
Novel Acinetobacter strain enables high-concentration biocatalysis for chiral acid production. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN102851238B reveals enzymatic hydrolysis breakthrough. Offers high purity and cost reduction in Pharmaceutical Intermediates manufacturing for global supply chains.